PL377413A1 - Pochodne piryd-2-onu i sposoby ich zastosowania - Google Patents
Pochodne piryd-2-onu i sposoby ich zastosowaniaInfo
- Publication number
- PL377413A1 PL377413A1 PL377413A PL37741303A PL377413A1 PL 377413 A1 PL377413 A1 PL 377413A1 PL 377413 A PL377413 A PL 377413A PL 37741303 A PL37741303 A PL 37741303A PL 377413 A1 PL377413 A1 PL 377413A1
- Authority
- PL
- Poland
- Prior art keywords
- pyrid
- derivatives
- methods
- Prior art date
Links
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43678702P | 2002-12-27 | 2002-12-27 | |
| US10/736,289 US20040147561A1 (en) | 2002-12-27 | 2003-12-12 | Pyrid-2-one derivatives and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377413A1 true PL377413A1 (pl) | 2006-02-06 |
Family
ID=32738277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377413A PL377413A1 (pl) | 2002-12-27 | 2003-12-22 | Pochodne piryd-2-onu i sposoby ich zastosowania |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040147561A1 (pl) |
| EP (1) | EP1575947A1 (pl) |
| JP (1) | JP2006514059A (pl) |
| AU (1) | AU2003299980A1 (pl) |
| CA (1) | CA2509213A1 (pl) |
| PL (1) | PL377413A1 (pl) |
| WO (1) | WO2004060890A1 (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1838675A1 (en) * | 2004-11-24 | 2007-10-03 | Laboratoires Serono S.A. | Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders |
| US8101770B2 (en) * | 2004-12-16 | 2012-01-24 | Vertex Pharmaceuticals Incorporated | Pyridones useful as inhibitors of kinases |
| EP1741709A1 (en) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| ATE548363T1 (de) * | 2005-08-29 | 2012-03-15 | Vertex Pharma | 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen |
| JPWO2008081711A1 (ja) | 2006-12-28 | 2010-04-30 | 三井化学アグロ株式会社 | ２−含フッ素アシル−３−アミノアクリロニトリル誘導体及びその製造方法 |
| EP2529793B1 (en) * | 2007-06-08 | 2016-08-10 | Georgia State University Research Foundation, Inc. | Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
| WO2008156644A2 (en) * | 2007-06-14 | 2008-12-24 | Frank David A | Stat modulators |
| CN102256963B (zh) | 2008-12-19 | 2014-06-11 | 贝林格尔.英格海姆国际有限公司 | 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺 |
| US8445517B2 (en) | 2009-12-11 | 2013-05-21 | Dana-Farber Cancer Institute | Stat modulators |
| ES2674275T3 (es) | 2009-12-17 | 2018-06-28 | Centrexion Therapeutics Corporation | Antagonistas del receptor CCR2 y usos de los mismos |
| CN102918034B (zh) | 2010-03-30 | 2015-06-03 | 维颂公司 | 多取代芳族化合物作为凝血酶的抑制剂 |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
| EP2632913A1 (en) | 2010-10-28 | 2013-09-04 | Syngenta Participations AG | Novel microbicides |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| LT2968297T (lt) | 2013-03-15 | 2019-01-10 | Verseon Corporation | Multipakeistieji aromatiniai junginiai kaip serino proteazės inhibitoriai |
| CN104013623B (zh) * | 2014-05-28 | 2016-01-20 | 中山大学 | 氰基-吡啶类化合物在制备抗hiv-1病毒药物中的应用 |
| CN106687445A (zh) | 2014-09-17 | 2017-05-17 | 维颂公司 | 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物 |
| AU2015369712B2 (en) | 2014-12-22 | 2020-05-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Mutant IDH1 inhibitors useful for treating cancer |
| RU2017131562A (ru) | 2015-02-27 | 2019-03-27 | Версеон Корпорейшн | Замещенные пиразольные соединения как ингибиторы сериновых протеаз |
| PL3303330T3 (pl) * | 2015-06-03 | 2019-10-31 | Bristol Myers Squibb Co | Agoniści 4 - hydroksy - 3 - ( heteroarylo ) pirydyno - 2 - onowi receptora apj do stosowania w leczeniu zaburzeń sercowo-naczyniowych |
| PT3317270T (pt) | 2015-07-02 | 2020-08-24 | Centrexion Therapeutics Corp | (4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona |
| CN110016023B (zh) * | 2018-01-08 | 2020-05-08 | 新发药业有限公司 | 一种帕博西尼的简便制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE599556A (pl) * | 1960-02-01 | |||
| DE3406329A1 (de) * | 1984-02-22 | 1985-08-22 | Merck Patent Gmbh, 6100 Darmstadt | Pyridone |
| CA2074933C (en) * | 1990-11-30 | 2002-12-03 | Masatoshi Chihiro | Thiazole derivatives as active superoxide radical inhibitors |
| US6150359A (en) * | 1997-08-20 | 2000-11-21 | Warner-Lambert Company | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| US20030055263A1 (en) * | 2001-07-11 | 2003-03-20 | Boehringer Ingelheim Pharma Kg | Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production |
| EP1432706A2 (en) * | 2001-09-26 | 2004-06-30 | Bayer Pharmaceuticals Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| US6822097B1 (en) * | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
-
2003
- 2003-12-12 US US10/736,289 patent/US20040147561A1/en not_active Abandoned
- 2003-12-22 CA CA002509213A patent/CA2509213A1/en not_active Abandoned
- 2003-12-22 AU AU2003299980A patent/AU2003299980A1/en not_active Abandoned
- 2003-12-22 JP JP2004565746A patent/JP2006514059A/ja active Pending
- 2003-12-22 WO PCT/US2003/041388 patent/WO2004060890A1/en not_active Ceased
- 2003-12-22 EP EP03800245A patent/EP1575947A1/en not_active Withdrawn
- 2003-12-22 PL PL377413A patent/PL377413A1/pl unknown
-
2006
- 2006-05-02 US US11/415,454 patent/US20060241151A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060241151A1 (en) | 2006-10-26 |
| JP2006514059A (ja) | 2006-04-27 |
| AU2003299980A1 (en) | 2004-07-29 |
| EP1575947A1 (en) | 2005-09-21 |
| WO2004060890A8 (en) | 2005-08-18 |
| WO2004060890A1 (en) | 2004-07-22 |
| CA2509213A1 (en) | 2004-07-22 |
| US20040147561A1 (en) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL377413A1 (pl) | Pochodne piryd-2-onu i sposoby ich zastosowania | |
| PL376532A1 (pl) | Pochodne podstawionych benzyloamin oraz sposoby wykorzystania | |
| AU2003235676A1 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| PL376566A1 (pl) | Pochodne podstawionych 2-alkiloamino-nikotynamidów oraz sposoby wykorzystania | |
| PL377861A1 (pl) | Podstawione pochodne aminowe oraz sposoby wykorzystania | |
| PL378294A1 (pl) | Pochodne izochinolinowe i sposoby ich stosowania | |
| ZA200500680B (en) | Quinoline derivatives and their use as mycrobacterial inhibitors | |
| AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
| EP1549614A4 (en) | VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION | |
| AU2003284808A8 (en) | The derivatives of pyridone and the use of them | |
| AU2003275311A1 (en) | Solid micro-perforators and methods of use | |
| IL156737A0 (en) | Substituted amine derivatives and methods of use | |
| AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
| PL375586A1 (pl) | Podstawione pochodne amidu kwasu antranilowego oraz sposoby wykorzystania | |
| AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
| EP1507756A4 (en) | CCR9 INHIBITORS AND USE THEREOF | |
| PL378331A1 (pl) | Tetracykliczne pochodne benzamidowe i sposoby ich stosowania | |
| EP1539692A4 (en) | FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| EP1551398A4 (en) | PYRAZOLOPYRIDINES AND METHODS OF MAKING AND USING THEM | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| AU2003251047A8 (en) | Use of quinoline derivatives with anti-integrase effect and applications thereof | |
| AU2003297612A8 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| AU2003215244A8 (en) | Complexes and methods of using same | |
| AU2002363938A8 (en) | Methods and use of motoneuronotropic factors | |
| AU2003287802A1 (en) | Palpometer and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |